{"id":5786,"date":"2024-09-19T08:36:34","date_gmt":"2024-09-19T13:36:34","guid":{"rendered":"https:\/\/nanostherapeutics.com\/?p=5786"},"modified":"2025-06-27T10:57:08","modified_gmt":"2025-06-27T15:57:08","slug":"nanoscope-therapeutics-to-be-featured-at-annual-euretina-congress-in-barcelona-2","status":"publish","type":"post","link":"https:\/\/nanostherapeutics.com\/ja\/2024\/09\/19\/nanoscope-therapeutics-to-be-featured-at-annual-euretina-congress-in-barcelona-2\/","title":{"rendered":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u3001\u30d0\u30eb\u30bb\u30ed\u30ca\u3067\u958b\u50ac\u3055\u308c\u308bEUretina\u5e74\u6b21\u4f1a\u8b70\u3067\u7279\u96c6\u3055\u308c\u308b"},"content":{"rendered":"
\n
\n
\n

<\/h1>\n<\/div>\n<\/div>\n<\/div>\n
\n
\n
\n
\n

\u30c0\u30e9\u30b9<\/span><\/span>,\u00a02024\u5e749\u670819\u65e5<\/span><\/span>\u00a0\/PRNewswire\/ \u2014\u00a0\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u682a\u5f0f\u4f1a\u793e<\/a>\u907a\u4f1d\u6027\u7db2\u819c\u75be\u60a3\uff08IRD\uff09\u304a\u3088\u3073\u9ec4\u6591\u5909\u6027\u306b\u4f34\u3046\u5730\u56f3\u72b6\u840e\u7e2e\u306b\u5bfe\u3059\u308b\u907a\u4f1d\u5b50\u6cbb\u7642\u3092\u958b\u767a\u3057\u3066\u3044\u308b\u81e8\u5e8a\u6bb5\u968e\u306e\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u4f01\u696d\u3067\u3042\u308b\u306f\u3001\u672c\u65e5\u3001\u00a024\u756a\u76ee<\/sup>\u00a0\u30e6\u30fc\u30ec\u30c6\u30a3\u30ca\u4f1a\u8b70<\/a>\u00a0\u958b\u50ac\u4e2d\u00a09\u670819\u65e5<\/span>\u756a\u76ee<\/sup>-22nd<\/sup>\u00a0\u3067\u00a0\u30d0\u30eb\u30bb\u30ed\u30ca\u3001\u30b9\u30da\u30a4\u30f3<\/span>.<\/p>\n

\u8b1b\u6f14\u5185\u5bb9\u306e\u8a73\u7d30\u306f\u4ee5\u4e0b\u306e\u901a\u308a\u3067\u3059\u3002<\/p>\n

\u30bf\u30a4\u30c8\u30eb\uff1a<\/b>\u00a0\u7db2\u819c\u8272\u7d20\u5909\u6027\u75c7\u306b\u5bfe\u3059\u308bMCO-010\u5909\u7570\u975e\u4f9d\u5b58\u578b\u5149\u907a\u4f1d\u5b66\u7684\u4f4e\u7528\u91cf\u307e\u305f\u306f\u9ad8\u7528\u91cf\u6cbb\u7642\u3092\u53d7\u3051\u305f\u60a3\u8005\u306b\u304a\u3051\u308bBCVA\u306e\u7e26\u65ad\u7684AUC\u5206\u6790\uff1a\u30d5\u30a7\u30fc\u30ba1\u8a66\u9a13\u306e100\u9031\u9593\u306eTOPLINE\u7d50\u679c\u00a02b<\/span>\/3 \u30e9\u30f3\u30c0\u30e0\u5316\u3001\u6a21\u64ec\u5bfe\u7167\u81e8\u5e8a\u8a66\u9a13 (RESTORE)<\/a>
\u30bb\u30c3\u30b7\u30e7\u30f3\u65e5:\u00a0<\/b>2024\u5e749\u670821\u65e5<\/span>
\u30bb\u30c3\u30b7\u30e7\u30f3\u6642\u9593:\u00a0<\/b>\u5348\u524d9\u664236\u5206\uff08\u4e2d\u592e\u30e8\u30fc\u30ed\u30c3\u30d1\u590f\u6642\u9593\uff09<\/span>
\u4f4d\u7f6e\uff1a<\/b>115,\u00a0\u30d0\u30eb\u30bb\u30ed\u30ca\u56fd\u969b\u4f1a\u8b70\u30bb\u30f3\u30bf\u30fc<\/a>
\u30d7\u30ec\u30bc\u30f3\u30bf\u30fc\uff1a\u00a0<\/b>\u30b8\u30e7\u30eb\u30c7\u30a3\u30fb\u30e2\u30cd\u30b9\u533b\u5b66\u535a\u58eb\u3001\u30de\u30ad\u30e5\u30e9\u7814\u7a76\u6240\u6240\u9577\u3001\u30d0\u30eb\u30bb\u30ed\u30ca\u30fb\u30de\u30ad\u30e5\u30e9\u8ca1\u56e3\uff08\u30b9\u30da\u30a4\u30f3<\/span>)<\/p>\n

\u30e2\u30cd\u30b9\u535a\u58eb\u306f\u3001\u5358\u4e00\u6642\u70b9\uff08\u4e3b\u8981\u8a55\u4fa1\u9805\u76ee\u304a\u3088\u3073\u4e3b\u8981\u306a\u526f\u6b21\u8a55\u4fa1\u9805\u76ee\uff09\u3067\u306e\u6709\u52b9\u6027\u306e\u4e00\u822c\u7684\u306a\u6e2c\u5b9a\u306b\u52a0\u3048\u3066\u3001RESTORE\u306e2\u5e74\u9593\u306e\u89b3\u5bdf\u671f\u9593\u5168\u4f53\u306b\u308f\u305f\u308b\u6cbb\u7642\u52b9\u679c\u3092\u6349\u3048\u308b\u66f2\u7dda\u4e0b\u9762\u7a4d\uff08AUC\uff09\u6cd5\u3092\u4f7f\u7528\u3057\u3066\u3001\u591a\u7279\u6027\u30aa\u30d7\u30b7\u30f3\uff08MCO-010\uff09\u3067\u6cbb\u7642\u3057\u305f\u7db2\u819c\u8272\u7d20\u5909\u6027\u75c7\u60a3\u8005\u306e\u6700\u9ad8\u77ef\u6b63\u8996\u529b\uff08BCVA\uff09\u306e\u6709\u52b9\u6027\u5206\u6790\u3092\u767a\u8868\u3057\u307e\u3059\u3002\u30b8\u30e7\u30eb\u30c7\u30a3\u30fb\u30e2\u30cd\u30b9\u6559\u6388\uff08\u30b9\u30da\u30a4\u30f3<\/span>\uff09\u306f\u3001\u00a0\u885b\u661f\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0<\/a>\u00a0IRD\u3068\u5730\u56f3\u72b6\u840e\u7e2e\u306b\u5bfe\u3059\u308b\u5149\u907a\u4f1d\u5b66\u6cbb\u7642\u306b\u7126\u70b9\u3092\u5f53\u3066\u305f\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u3067\u3059\u3002\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u306e\u8a73\u7d30\u306f\u4ee5\u4e0b\u306e\u901a\u308a\u3067\u3059\u3002<\/p>\n

\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\u30bf\u30a4\u30c8\u30eb:\u00a0<\/b>\u7db2\u819c\u5909\u6027\u75be\u60a3\u306b\u5bfe\u3059\u308b\u5149\u907a\u4f1d\u5b66\u7684\u6cbb\u7642 - \u81e8\u5e8a\u958b\u767a\u3068\u6700\u65b0\u60c5\u5831<\/a>
\u65e5\u4ed8\uff1a\u00a0<\/b>2024\u5e749\u670820\u65e5<\/span>
\u6642\u9593\uff1a\u00a0<\/b>\u5348\u524d9\u664245\u5206\uff5e\u5348\u524d10\u664245\u5206\uff08\u4e2d\u592e\u30e8\u30fc\u30ed\u30c3\u30d1\u590f\u6642\u9593\uff09<\/span>
\u5348\u524d9\u664245\u5206\uff08CEST\uff09: \u958b\u4f1a\u306e\u6328\u62f6\u3001\u30b8\u30e7\u30eb\u30c7\u30a3\u30fb\u30e2\u30cd\u30b9\u533b\u5b66\u535a\u58eb\uff08\u30b9\u30da\u30a4\u30f3<\/span>)
\u5348\u524d 9 \u6642 48 \u5206 CEST: \u7db2\u819c\u5909\u6027\u75be\u60a3\u3001Arshad Khanani\u3001MA\u3001MD\u3001FASRS (\u30a2\u30e1\u30ea\u30ab\u5408\u8846\u56fd<\/span>)
\u5348\u524d9\u664258\u5206 CEST: IRD\u306b\u5bfe\u3059\u308b\u5149\u907a\u4f1d\u5b66\u7684\u6cbb\u7642\u3001\u00a0\u30d1\u30a6\u30ed\u30fb\u30b9\u30bf\u30f3\u30ac<\/span>\u3001MD\uff08\u82f1\u56fd\uff09
\u5348\u524d 10:08 CEST: \u9ec4\u6591\u5909\u6027\u75c7\u306b\u5bfe\u3059\u308b\u5149\u907a\u4f1d\u5b66\u7684\u6cbb\u7642\u3001\u30b8\u30e7\u30eb\u30c7\u30a3 \u30e2\u30cd\u30b9\u3001\u533b\u5b66\u535a\u58eb\u3001\u535a\u58eb (\u30b9\u30da\u30a4\u30f3<\/span>)
\u5348\u524d10\u664218\u5206\uff08\u4e2d\u592e\u30e8\u30fc\u30ed\u30c3\u30d1\u590f\u6642\u9593\uff09<\/span>: \u30aa\u30d7\u30c8\u30b8\u30a7\u30cd\u30c6\u30a3\u30af\u30b9\u306b\u3088\u308b\u4f4e\u8996\u529b\u60a3\u8005\u306e\u6cbb\u7642\u306b\u304a\u3051\u308b\u753b\u50cf\u8a3a\u65ad\u3068\u6709\u52b9\u6027\u8a55\u4fa1\u3001\u00a0\u30a6\u30b7\u30e3\u30fb\u30c1\u30e3\u30af\u30e9\u30f4\u30a1\u30eb\u30c6\u30a3<\/span>\u3001MD\uff08\u82f1\u56fd\uff09
10:28 CEST: \u8cea\u7591\u5fdc\u7b54\u3001\u5168\u8b1b\u6f14\u8005\u3001\u53f8\u4f1a\uff1a\u30d5\u30e9\u30f3\u30c1\u30a7\u30b9\u30b3\u30fb\u30d0\u30f3\u30c7\u30c3\u30ed\u6559\u6388\uff08\u533b\u5b66\u535a\u58eb\uff09\uff08\u30a4\u30bf\u30ea\u30a2<\/span>)
\u4f4d\u7f6e\uff1a<\/b>118\/119,\u00a0\u30d0\u30eb\u30bb\u30ed\u30ca\u56fd\u969b\u4f1a\u8b70\u30bb\u30f3\u30bf\u30fc<\/a><\/p>\n

\u7d4c\u55b6\u9663\u306f\u4f1a\u8b70\u306b\u51fa\u5e2d\u3057\u3001\u4f1a\u8b70\u306b\u53c2\u52a0\u3067\u304d\u307e\u3059\u3002<\/p>\n

\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e\u306b\u3064\u3044\u3066
<\/b>Nanoscope Therapeutics \u306f\u3001\u6cbb\u7642\u6cd5\u304c\u5b58\u5728\u3057\u306a\u3044\u7db2\u819c\u5909\u6027\u75be\u60a3\u306b\u3088\u308a\u5931\u660e\u3057\u305f\u4f55\u767e\u4e07\u4eba\u3082\u306e\u60a3\u8005\u3092\u5bfe\u8c61\u306b\u3001\u907a\u4f1d\u5b50\u306b\u4f9d\u5b58\u305b\u305a\u8996\u529b\u3092\u56de\u5fa9\u3059\u308b\u5149\u907a\u4f1d\u5b66\u7684\u6cbb\u7642\u6cd5\u3092\u958b\u767a\u3057\u3066\u3044\u307e\u3059\u3002\u540c\u793e\u306e\u4e3b\u8981\u8cc7\u7523\u3067\u3042\u308b MCO-010 \u306f\u3001\u7c73\u56fd\u3067\u7db2\u819c\u8272\u7d20\u5909\u6027\u75c7\u3092\u5bfe\u8c61\u3068\u3057\u305f RESTORE \u7b2c 2b \u76f8\u591a\u65bd\u8a2d\u7121\u4f5c\u70ba\u5316\u4e8c\u91cd\u30de\u30b9\u30af\u507d\u5bfe\u7167\u81e8\u5e8a\u8a66\u9a13\u306e\u30c8\u30c3\u30d7\u30e9\u30a4\u30f3\u7d50\u679c\u3092\u6700\u8fd1\u5831\u544a\u3057\u307e\u3057\u305f (NCT04945772<\/a>\u540c\u793e\u306f\u307e\u305f\u3001\u30b9\u30bf\u30fc\u30ac\u30eb\u30c8\u75c5\u60a3\u8005\u3092\u5bfe\u8c61\u3068\u3057\u305fMCO-010\u7642\u6cd5\u306e\u7b2c2\u76f8STARLIGHT\u8a66\u9a13\u3092\u5b8c\u4e86\u3057\u305f\uff08NCT05417126<\/a>\uff09\u3068\u6700\u8fd1\u767a\u8868\u3055\u308c\u305f\u00a0\u30d5\u30a7\u30fc\u30ba3\u767b\u9332\u8a66\u9a13\u3092\u958b\u59cb\u3059\u308b\u4e88\u5b9a<\/a>MCO-010 \u306f\u3001RP \u3068 Stargardt \u306e\u4e21\u65b9\u3067 FDA \u30d5\u30a1\u30b9\u30c8 \u30c8\u30e9\u30c3\u30af\u6307\u5b9a\u3068 FDA \u5e0c\u5c11\u75be\u75c5\u7528\u533b\u85ac\u54c1\u6307\u5b9a\u3092\u53d7\u3051\u3066\u3044\u307e\u3059\u3002\u524d\u81e8\u5e8a\u8cc7\u7523\u306b\u306f\u3001\u5730\u56f3\u72b6\u840e\u7e2e\u306b\u5bfe\u3059\u308b\u975e\u30a6\u30a4\u30eb\u30b9\u6027\u30ec\u30fc\u30b6\u30fc\u9001\u9054 MCO-020 \u907a\u4f1d\u5b50\u6cbb\u7642\u304c\u542b\u307e\u308c\u307e\u3059\u3002<\/p>\n

\u6295\u8cc7\u5bb6\u9023\u7d61\u5148:<\/b>
\u30a2\u30eb\u30b4\u30c3\u30c8\u30d1\u30fc\u30c8\u30ca\u30fc\u30ba
(212) 600-1902
PR@nanostherapeutics.com<\/a><\/p>\n

\u51fa\u5178 \u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9<\/p>\n<\/div>\n<\/div>\n<\/section>\n<\/article>","protected":false},"excerpt":{"rendered":"

DALLAS,\u00a0Sept. 19, 2024\u00a0\/PRNewswire\/ \u2014\u00a0Nanoscope Therapeutics Inc., a clinical-stage biotechnology company developing gene therapies for inherited retinal diseases (IRDs) and geographic atrophy secondary to macular degeneration, today announced presentations at the\u00a024th\u00a0Euretina congress\u00a0taking place on\u00a0September 19th-22nd\u00a0in\u00a0Barcelona, Spain. Details for the presentations are as follows: Title:\u00a0Longitudinal AUC analysis of BCVA in patients treated with low- or high-dose MCO-010 mutation agnostic optogenetic therapy for retinitis pigmentosa: 100-week TOPLINE results from a Phase\u00a02b\/3 randomized, sham-controlled clinical trial (RESTORE)Session Date:\u00a0September 21, 2024Session Time:\u00a09:36 am CESTLocation:115,\u00a0Barcelona International Convention CenterPresenter:\u00a0Jordi Mon\u00e9s, MD, PhD, Director of Institut de la M\u00e0cula, and Barcelona Macula Foundation (Spain) In addition to typical measures of efficacy at single time points (primary and key […]<\/p>\n","protected":false},"author":6,"featured_media":5784,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[13,8],"tags":[],"class_list":["post-5786","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-home-page","category-nanoscope-press-release"],"yoast_head":"\nNanoscope Therapeutics to be Featured at Annual EUretina Congress in Barcelona - Nanoscope Therapeutics<\/title>\n<meta name=\"description\" content=\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nanostherapeutics.com\/ja\/2024\/09\/19\/nanoscope-therapeutics-to-be-featured-at-annual-euretina-congress-in-barcelona-2\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nanoscope Therapeutics to be Featured at Annual EUretina Congress in Barcelona - Nanoscope Therapeutics\" \/>\n<meta property=\"og:description\" content=\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nanostherapeutics.com\/ja\/2024\/09\/19\/nanoscope-therapeutics-to-be-featured-at-annual-euretina-congress-in-barcelona-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Nanoscope Therapeutics\" \/>\n<meta property=\"article:published_time\" content=\"2024-09-19T13:36:34+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-06-27T15:57:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/09\/NSCOPE_SyposiumFlyer.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"1005\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Nanoscope Therapeutics\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/09\/NSCOPE_SyposiumFlyer.jpg\" \/>\n<meta name=\"twitter:creator\" content=\"@NSTherapeutics\" \/>\n<meta name=\"twitter:site\" content=\"@NSTherapeutics\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"Nanoscope Therapeutics\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"3\u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/09\\\/19\\\/nanoscope-therapeutics-to-be-featured-at-annual-euretina-congress-in-barcelona-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/09\\\/19\\\/nanoscope-therapeutics-to-be-featured-at-annual-euretina-congress-in-barcelona-2\\\/\"},\"author\":{\"name\":\"Nanoscope Therapeutics\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/person\\\/5aeedc9aef0946fe8f96f98f7b1808a2\"},\"headline\":\"Nanoscope Therapeutics to be Featured at Annual EUretina Congress in Barcelona\",\"datePublished\":\"2024-09-19T13:36:34+00:00\",\"dateModified\":\"2025-06-27T15:57:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/09\\\/19\\\/nanoscope-therapeutics-to-be-featured-at-annual-euretina-congress-in-barcelona-2\\\/\"},\"wordCount\":441,\"publisher\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/09\\\/19\\\/nanoscope-therapeutics-to-be-featured-at-annual-euretina-congress-in-barcelona-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/NSCOPE_SyposiumFlyer.jpg\",\"articleSection\":[\"Home Page\",\"Nanoscope Press Release\"],\"inLanguage\":\"ja\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/09\\\/19\\\/nanoscope-therapeutics-to-be-featured-at-annual-euretina-congress-in-barcelona-2\\\/\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/09\\\/19\\\/nanoscope-therapeutics-to-be-featured-at-annual-euretina-congress-in-barcelona-2\\\/\",\"name\":\"Nanoscope Therapeutics to be Featured at Annual EUretina Congress in Barcelona - Nanoscope Therapeutics\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/09\\\/19\\\/nanoscope-therapeutics-to-be-featured-at-annual-euretina-congress-in-barcelona-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/09\\\/19\\\/nanoscope-therapeutics-to-be-featured-at-annual-euretina-congress-in-barcelona-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/NSCOPE_SyposiumFlyer.jpg\",\"datePublished\":\"2024-09-19T13:36:34+00:00\",\"dateModified\":\"2025-06-27T15:57:08+00:00\",\"description\":\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/09\\\/19\\\/nanoscope-therapeutics-to-be-featured-at-annual-euretina-congress-in-barcelona-2\\\/#breadcrumb\"},\"inLanguage\":\"ja\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/09\\\/19\\\/nanoscope-therapeutics-to-be-featured-at-annual-euretina-congress-in-barcelona-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/09\\\/19\\\/nanoscope-therapeutics-to-be-featured-at-annual-euretina-congress-in-barcelona-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/NSCOPE_SyposiumFlyer.jpg\",\"contentUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/NSCOPE_SyposiumFlyer.jpg\",\"width\":800,\"height\":1005},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2024\\\/09\\\/19\\\/nanoscope-therapeutics-to-be-featured-at-annual-euretina-congress-in-barcelona-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nanostherapeutics.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nanoscope Therapeutics to be Featured at Annual EUretina Congress in Barcelona\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#website\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/\",\"name\":\"Nanoscope Therapeutics\",\"description\":\"Bringing Back the Light of Hope\",\"publisher\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\"},\"alternateName\":\"Nanoscope Therapeutics\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nanostherapeutics.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ja\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\",\"name\":\"Nanoscope Therapeutics, Inc\",\"alternateName\":\"Nanoscope Therapeutics\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/NSCOPE_Logo_Stack_2Color_512.png\",\"contentUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/NSCOPE_Logo_Stack_2Color_512.png\",\"width\":512,\"height\":435,\"caption\":\"Nanoscope Therapeutics, Inc\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/NSTherapeutics\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/nanoscope\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/person\\\/5aeedc9aef0946fe8f96f98f7b1808a2\",\"name\":\"Nanoscope Therapeutics\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e\u304c\u30d0\u30eb\u30bb\u30ed\u30ca\u3067\u958b\u50ac\u3055\u308c\u308bEUretina\u5e74\u6b21\u4f1a\u8b70\u3067\u7279\u96c6\u3055\u308c\u308b\u4e88\u5b9a - \u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e","description":"\u5f53\u793e\u306e\u591a\u6a5f\u80fd\u30aa\u30d7\u30b7\u30f3\uff08MCO\uff09\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306f\u3001\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3044\u3066\u91cd\u5ea6\u306e\u8996\u529b\u55aa\u5931\u3092\u4f34\u3046\u7db2\u819c\u75be\u60a3\u60a3\u8005\u306e\u8996\u529b\u3092\u56de\u5fa9\u3055\u305b\u308b\u80fd\u529b\u3092\u5b9f\u8a3c\u3057\u305f\u521d\u306e\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3067\u3059\u3002Nanoscope\u793e\u306f\u3001\u907a\u4f1d\u5b50\u306b\u4f9d\u5b58\u3057\u306a\u3044\u3001\u5e83\u7bc4\u56f2\u306e\u30b9\u30da\u30af\u30c8\u30eb\u3001\u9ad8\u901f\u5fdc\u7b54\u6027\u3001\u8d85\u9ad8\u611f\u5ea6\u3092\u5099\u3048\u305f\u3001\u8996\u529b\u56de\u5fa9\u306e\u305f\u3081\u306e\u6700\u521d\u3067\u552f\u4e00\u306e\u5149\u907a\u4f1d\u5b66\u6280\u8853\u3067\u3042\u308bMCO-010\u3092\u958b\u767a\u3057\u307e\u3057\u305f\u3002.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nanostherapeutics.com\/ja\/2024\/09\/19\/nanoscope-therapeutics-to-be-featured-at-annual-euretina-congress-in-barcelona-2\/","og_locale":"ja_JP","og_type":"article","og_title":"Nanoscope Therapeutics to be Featured at Annual EUretina Congress in Barcelona - Nanoscope Therapeutics","og_description":"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.","og_url":"https:\/\/nanostherapeutics.com\/ja\/2024\/09\/19\/nanoscope-therapeutics-to-be-featured-at-annual-euretina-congress-in-barcelona-2\/","og_site_name":"Nanoscope Therapeutics","article_published_time":"2024-09-19T13:36:34+00:00","article_modified_time":"2025-06-27T15:57:08+00:00","og_image":[{"width":800,"height":1005,"url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/09\/NSCOPE_SyposiumFlyer.jpg","type":"image\/jpeg"}],"author":"Nanoscope Therapeutics","twitter_card":"summary_large_image","twitter_image":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/09\/NSCOPE_SyposiumFlyer.jpg","twitter_creator":"@NSTherapeutics","twitter_site":"@NSTherapeutics","twitter_misc":{"\u57f7\u7b46\u8005":"Nanoscope Therapeutics","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"3\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nanostherapeutics.com\/2024\/09\/19\/nanoscope-therapeutics-to-be-featured-at-annual-euretina-congress-in-barcelona-2\/#article","isPartOf":{"@id":"https:\/\/nanostherapeutics.com\/2024\/09\/19\/nanoscope-therapeutics-to-be-featured-at-annual-euretina-congress-in-barcelona-2\/"},"author":{"name":"Nanoscope Therapeutics","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/person\/5aeedc9aef0946fe8f96f98f7b1808a2"},"headline":"Nanoscope Therapeutics to be Featured at Annual EUretina Congress in Barcelona","datePublished":"2024-09-19T13:36:34+00:00","dateModified":"2025-06-27T15:57:08+00:00","mainEntityOfPage":{"@id":"https:\/\/nanostherapeutics.com\/2024\/09\/19\/nanoscope-therapeutics-to-be-featured-at-annual-euretina-congress-in-barcelona-2\/"},"wordCount":441,"publisher":{"@id":"https:\/\/nanostherapeutics.com\/#organization"},"image":{"@id":"https:\/\/nanostherapeutics.com\/2024\/09\/19\/nanoscope-therapeutics-to-be-featured-at-annual-euretina-congress-in-barcelona-2\/#primaryimage"},"thumbnailUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/09\/NSCOPE_SyposiumFlyer.jpg","articleSection":["Home Page","Nanoscope Press Release"],"inLanguage":"ja"},{"@type":"WebPage","@id":"https:\/\/nanostherapeutics.com\/2024\/09\/19\/nanoscope-therapeutics-to-be-featured-at-annual-euretina-congress-in-barcelona-2\/","url":"https:\/\/nanostherapeutics.com\/2024\/09\/19\/nanoscope-therapeutics-to-be-featured-at-annual-euretina-congress-in-barcelona-2\/","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e\u304c\u30d0\u30eb\u30bb\u30ed\u30ca\u3067\u958b\u50ac\u3055\u308c\u308bEUretina\u5e74\u6b21\u4f1a\u8b70\u3067\u7279\u96c6\u3055\u308c\u308b\u4e88\u5b9a - \u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e","isPartOf":{"@id":"https:\/\/nanostherapeutics.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nanostherapeutics.com\/2024\/09\/19\/nanoscope-therapeutics-to-be-featured-at-annual-euretina-congress-in-barcelona-2\/#primaryimage"},"image":{"@id":"https:\/\/nanostherapeutics.com\/2024\/09\/19\/nanoscope-therapeutics-to-be-featured-at-annual-euretina-congress-in-barcelona-2\/#primaryimage"},"thumbnailUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/09\/NSCOPE_SyposiumFlyer.jpg","datePublished":"2024-09-19T13:36:34+00:00","dateModified":"2025-06-27T15:57:08+00:00","description":"\u5f53\u793e\u306e\u591a\u6a5f\u80fd\u30aa\u30d7\u30b7\u30f3\uff08MCO\uff09\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306f\u3001\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3044\u3066\u91cd\u5ea6\u306e\u8996\u529b\u55aa\u5931\u3092\u4f34\u3046\u7db2\u819c\u75be\u60a3\u60a3\u8005\u306e\u8996\u529b\u3092\u56de\u5fa9\u3055\u305b\u308b\u80fd\u529b\u3092\u5b9f\u8a3c\u3057\u305f\u521d\u306e\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3067\u3059\u3002Nanoscope\u793e\u306f\u3001\u907a\u4f1d\u5b50\u306b\u4f9d\u5b58\u3057\u306a\u3044\u3001\u5e83\u7bc4\u56f2\u306e\u30b9\u30da\u30af\u30c8\u30eb\u3001\u9ad8\u901f\u5fdc\u7b54\u6027\u3001\u8d85\u9ad8\u611f\u5ea6\u3092\u5099\u3048\u305f\u3001\u8996\u529b\u56de\u5fa9\u306e\u305f\u3081\u306e\u6700\u521d\u3067\u552f\u4e00\u306e\u5149\u907a\u4f1d\u5b66\u6280\u8853\u3067\u3042\u308bMCO-010\u3092\u958b\u767a\u3057\u307e\u3057\u305f\u3002.","breadcrumb":{"@id":"https:\/\/nanostherapeutics.com\/2024\/09\/19\/nanoscope-therapeutics-to-be-featured-at-annual-euretina-congress-in-barcelona-2\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nanostherapeutics.com\/2024\/09\/19\/nanoscope-therapeutics-to-be-featured-at-annual-euretina-congress-in-barcelona-2\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/nanostherapeutics.com\/2024\/09\/19\/nanoscope-therapeutics-to-be-featured-at-annual-euretina-congress-in-barcelona-2\/#primaryimage","url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/09\/NSCOPE_SyposiumFlyer.jpg","contentUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2024\/09\/NSCOPE_SyposiumFlyer.jpg","width":800,"height":1005},{"@type":"BreadcrumbList","@id":"https:\/\/nanostherapeutics.com\/2024\/09\/19\/nanoscope-therapeutics-to-be-featured-at-annual-euretina-congress-in-barcelona-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nanostherapeutics.com\/"},{"@type":"ListItem","position":2,"name":"Nanoscope Therapeutics to be Featured at Annual EUretina Congress in Barcelona"}]},{"@type":"WebSite","@id":"https:\/\/nanostherapeutics.com\/#website","url":"https:\/\/nanostherapeutics.com\/","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9","description":"\u5e0c\u671b\u306e\u5149\u3092\u53d6\u308a\u623b\u3059","publisher":{"@id":"https:\/\/nanostherapeutics.com\/#organization"},"alternateName":"Nanoscope Therapeutics","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nanostherapeutics.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Organization","@id":"https:\/\/nanostherapeutics.com\/#organization","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e","alternateName":"Nanoscope Therapeutics","url":"https:\/\/nanostherapeutics.com\/","logo":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/logo\/image\/","url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_Logo_Stack_2Color_512.png","contentUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_Logo_Stack_2Color_512.png","width":512,"height":435,"caption":"Nanoscope Therapeutics, Inc"},"image":{"@id":"https:\/\/nanostherapeutics.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/NSTherapeutics","https:\/\/www.linkedin.com\/company\/nanoscope"]},{"@type":"Person","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/person\/5aeedc9aef0946fe8f96f98f7b1808a2","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9"}]}},"_links":{"self":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts\/5786","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/comments?post=5786"}],"version-history":[{"count":2,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts\/5786\/revisions"}],"predecessor-version":[{"id":9017,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts\/5786\/revisions\/9017"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/media\/5784"}],"wp:attachment":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/media?parent=5786"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/categories?post=5786"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/tags?post=5786"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}